Login to Your Account

4SC, Yakult Honsha take HCC therapy forward into phase II

By Kristine Yang
Staff Writer

Tuesday, September 30, 2014
HONG KONG – A German-Japanese effort to develop a first-line therapy for advanced Asian hepatocellular carcinoma (HCC) recently hit an important milestone with the completion of a phase I trial and the launch of phase II development.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription